Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Navigating COVID-19 antiviral access criteria
Wednesday 20 July 2022, 12:20 AM

ECG supplied
Consultant cardiologist Chris Ellis looks at the COVID-19 antiviral treatments available for use in New Zealand, including the current access criteria set by Pharmac
Late news, As we went to press, Pharmac announced that, effective from 18 July, the COVID-19 antiviral access criteria widened to include all people aged 75 and , Educ Blue w pale blue
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med 2022;386(6):509–20.
2. Hammond J, Leister-Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med 2022;386(15):1397–408.